Is RCDTF or NOBL a better dividend investment in 2026?

RCDTF currently yields 2.77% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: RCDTF offers higher current income.

What is the dividend yield difference between RCDTF and NOBL?

RCDTF has a forward dividend yield of 2.77% ($1.58/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 0.60 percentage points.

Home › Compare › RCDTF vs NOBL

RCDTF vs NOBL: Dividend Comparison 2026

RCDTF yields 2.77% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RCDTF wins by $29.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RCDTF

● Live price

2.77%

Share price

$56.95

Annual div

$1.58

5Y div CAGR

32%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$52.6K

Annual income

$9,708.55

Full RCDTF calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — RCDTF vs NOBL

📍 RCDTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RCDTF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RCDTF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RCDTF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCDTF

Annual income on $10K today (after 15% tax)

$235.82/yr

After 10yr DRIP, annual income (after tax)

$8,252.27/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, RCDTF beats the other by $8,039.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCDTF + NOBL for your $10,000?

RCDTF: 50%NOBL: 50%

100% NOBL50/50100% RCDTF

Portfolio after 10yr

$37.7K

Annual income

$4,979.17/yr

Blended yield

13.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NOBL right now

RCDTF

Analyst Ratings

Hold

Sell

Consensus: Hold

Altman Z

3.4

Piotroski

5/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCDTF buys

NOBL buys

No recent congressional trades found for RCDTF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRCDTFNOBL

Forward yield	2.77% ✓	2.17%
Annual dividend / share	$1.58	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	32% ✓	0%
Portfolio after 10y	$52.6K ✓	$22.9K
Annual income after 10y	$9,708.55 ✓	$249.78
Total dividends collected	$28.6K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RCDTF vs NOBL ($10,000, DRIP)

Year	RCDTF Portfolio	RCDTF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$11,066	$366.22	$10,917	$217.08	+$149.00 → RCDTF
2	$12,341	$499.95	$11,903	$221.48	+$438.00 → RCDTF
3	$13,892	$687.80	$12,962	$225.68	+$930.00 → RCDTF
4	$15,820	$955.18	$14,099	$229.68	+$1.7K → RCDTF
5	$18,269	$1,341.86	$15,319	$233.49	+$3.0K → RCDTF
6	$21,460	$1,911.67	$16,628	$237.10	+$4.8K → RCDTF
7	$25,732	$2,770.17	$18,033	$240.53	+$7.7K → RCDTF
8	$31,631	$4,097.76	$19,539	$243.78	+$12.1K → RCDTF
9	$40,060	$6,214.06	$21,154	$246.86	+$18.9K → RCDTF
10	$52,572	$9,708.55	$22,884	$249.78	+$29.7K → RCDTF

RCDTF vs NOBL: Complete Analysis 2026

RCDTF — Stock

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Full RCDTF Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this RCDTF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCDTF vs SCHD RCDTF vs JEPI RCDTF vs O RCDTF vs KO RCDTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.